AstraZeneca/Oxford vaccine shows promise for older adults

AstraZeneca and the University of Oxford’s coronavirus vaccine produces an immune response in older adults similar to that in younger adults.

A new study published in the British medical journal Lancet shows that the Phase 2 trial of the AstraZeneca/Oxford vaccine found that antibody and T-cell responses in people aged 56-69 and those 70 and older were similar to those between the ages of 18 and 55.

The results also show that the vaccine may be better tolerated in older adults. Among those who received both doses of the vaccine, systemic reactions such as fevers and rashes occurred in 88% of those ages 18-55, while occurring only in 77%
Read more…

Please follow and like us: